Diagnosis and acute management of migraine
Date Added:
February 8, 2023
Journal/Publication:
CMAJ
Publisher:
CMA Impact Inc
Publication Date:
January 30, 2023
Issue:
4
Volume:
195
Pages:
E153-E158
Type:
Meta-analyses, Reviews, and Guidelines
Format:
Article
DOI (1):
10.1503/cmaj.211969
PMID (1):
36717129
Abstract
Migraine is a leading cause of disability across all age groups.
• Routine imaging is not recommended in patients with migraine
who have no red flags, atypical symptoms or abnormal findings
on neurologic examination.
• A stratified approach for acute migraine treatment empowers
patients to choose from different treatment options
depending on attack symptoms and severity and encourages
patients to combine medications from different classes.
• Effective acute migraine treatment includes acetaminophen,
nonsteroidal anti-inflammatory drugs and triptans.
• Ubrogepant and rimegepant are new, effective migraine
treatments, suitable for patients with cardiovascular disease in
whom triptans are contraindicated.
Text Availability
Free full text
RPR Commentary
A concise review of the presumed cause and treatment of migraine headaches. James W. Mold, MD, MPH